Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
NRG-GI003
Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer
- NCT03186898 ↗
- Active, not recruiting
- NRG Oncology
- Deep
We haven't built an HCP commentary report on NRG-GI003 (Recurrent Hepatocellular Carcinoma) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NRG-GI003 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 26 | |
| YouTube | 4 | |
| Podcasts | 3 | |
| Bluesky threads | 1 |
The trial
ClinicalTrials.gov- Official title
- A Phase III Randomized Trial of Protons Versus Photons for Hepatocellular Carcinoma
- Phase
- Phase 3
- Status
- Active, not recruiting
- Conditions
- Recurrent Hepatocellular Carcinoma; Stage III Hepatocellular Carcinoma AJCC v7; Unresectable Hepatocellular Carcinoma
- Interventions
- Biospecimen Collection; Computed Tomography; Laboratory Biomarker Analysis; Magnetic Resonance Imaging; Quality-of-Life Assessment; Radiation Therapy; Radiation Therapy
- Arms
- Arm I (proton therapy) · Experimental
- Arm II (photon therapy) · Experimental
- Enrollment
- 115
- Primary outcomes
- Overall survival (OS)
- Treatment effect
- Sponsor
- NRG Oncology with National Cancer Institute (NCI)
- Start
- Jan 26, 2018
- Primary completion
- Jan 20, 2026
- Results posted
- No
- Registry record
- NCT03186898 · updated Jul 2, 2026
Publications
linked from the registry- Duda DG. Targeting Tumor Microenvironment in Liver Cancers: Rationale, Current Progress, and Future Perspective. Keio J Med. 2022;71(3):71. doi: 10.2302/kjm.71-004-ABST. PubMed 36155490